Cancer studies can be underpowered for several reasons:
Small sample size: Recruiting enough patients can be challenging, especially for rare cancers. Resource constraints: Limited funding and resources can restrict the scope of a study. Study design flaws: Poor planning and methodology can lead to insufficient power. Heterogeneity: Variability among patients can dilute the effects being measured.
